Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementability and Health Impact of Proactive Cardiovascular Prevention Strategy in Subjects With High Genetic Risk: a Randomized Pilot Study

NCT04291157 is registered in ClinicalTrials.gov with Alar Irs as lead sponsor.

NCT NCT04291157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04291157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementability and Health Impact of Proactive Cardiovascular Prevention Strategy in Subjects With High Genetic Risk: a Randomized Pilot Study
Lead sponsor
Alar Irs
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2019
Completion date
December 31, 2020
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, primary prevention